<DOC>
	<DOCNO>NCT01697540</DOCNO>
	<brief_summary>1 . Written informed consent must obtain study specific procedure undertaken . 2 . The process experiment ( brief describe ) The patient must come back follow 4 12 week start new therapy . The investigator follow patient ' lipid profile side effect stop observation till 36 month start new therapy . The serum level HIV-VL , CD4 , GOT , GPT , triglyceride , cholesterol , HDL-cholesterol , LDL-cholesterol check every 3 month . The patient ' chart data delinked protect patient ' right privacy .</brief_summary>
	<brief_title>Management Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients Taiwan</brief_title>
	<detailed_description />
	<criteria>HIVinfected patient receive HAART therapy metabolic side effect . Age 20 year old Abnormal liver function : GOT GPT 5 time normal upper limit</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>